Aflac (NYSE:AFL – Get Free Report) will likely be issuing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Aflac to announce earnings of $1.76 per share and revenue of $4.1066 billion for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 7, 2026 at 8:00 AM ET.
Aflac Price Performance
Shares of AFL opened at $125.32 on Wednesday. The firm has a market capitalization of $63.78 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 1.95 and a beta of 0.60. The firm’s fifty day simple moving average is $119.99 and its 200-day simple moving average is $115.08. Aflac has a twelve month low of $97.47 and a twelve month high of $130.22. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.26.
Insider Buying and Selling
In other news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $118.12, for a total value of $7,441,560.00. Following the completion of the sale, the insider directly owned 51,169,435 shares of the company’s stock, valued at approximately $6,044,133,662.20. This represents a 0.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 744,673 shares of company stock worth $87,090,808 over the last quarter. Insiders own 0.80% of the company’s stock.
Institutional Trading of Aflac
Analyst Ratings Changes
Several equities analysts recently commented on the company. Barclays dropped their target price on Aflac from $99.00 to $98.00 and set an “underweight” rating on the stock in a report on Tuesday, July 7th. TD Cowen reiterated a “hold” rating and issued a $110.00 price objective (up from $101.00) on shares of Aflac in a report on Wednesday, July 22nd. Mizuho set a $112.00 target price on Aflac in a research report on Thursday, July 9th. Evercore upgraded Aflac from a “strong sell” rating to a “strong-buy” rating in a research note on Thursday, April 9th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $108.00 price target (up from $100.00) on shares of Aflac in a report on Friday, July 10th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $116.17.
Get Our Latest Stock Analysis on Aflac
Aflac Company Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Featured Stories
- Five stocks we like better than Aflac
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
